<p>(A) Percentage of peripheral blood cells in specific hematopoietic lineages at 30 weeks after transplantation. Each dot represents the percent of cells from a given lineage, as determined by flow cytometry, from a single primary transplant recipient from each of the vector groups listed on the X-axis. Statistical comparisons are shown for the indicated groups giving the p value. This analysis demonstrated a significant increase in cells expressing either the Gr1 or the Mac1 marker. (B) Percentage of DsRed+ peripheral blood cells in each lineage in the SFFV group of primary recipients at 30 weeks after transplant. Each line represents the profile from a single mouse and the lineages are indicated on the X-axis.</p
<p>Analyses were performed on day 14 after second transplantation. (A) Continuous HSCT: To evaluate ...
<p>Peripheral blood chimerism analysis (% of hCD45<sup>+</sup> cells) was performed by flow cytometr...
<p>Blood chimerism was assessed by flow cytometry 8 weeks following transplantation of GFP<sup>+/-</...
<p>(A) Hematologic characteristics of myeloid leukemias including peripheral leukocyte counts and sp...
<p>C57Bl/6 mice were reconstituted with BM cells transduced with control MigR1 or <i>Nfix</i> vector...
<p>NSGS mice transplanted with control cells (MIG mice) and <i>BCR-ABL1</i> expressing cells (BA mic...
Representative flow plots from week 16 engrafted mice showing lineage distribution in A) spleen and ...
<p>C57Bl/6 mice were reconstituted with BM cells transduced with control MigR1 or <i>Nfix</i> vector...
<p>(<b>A</b>) Proportion of <i>Crebbp</i><sup><i>+/-</i></sup> cell-derived reconstitution (CD45.2<s...
<p>(A) and (B) Two months following BM transplantation, the four groups of mice were sacrificed and ...
<p>(A) Frequencies of GFP<sup>+</sup>/Venus<sup>+</sup> cells or human CD45<sup>+</sup> cells in the...
A) Averages and B) representative FACS analysis of UCB-engrafted BM demonstrating higher CD33+ and l...
<p>1×10<sup>6</sup> CD45.1 WBMCs were transplanted into lethally irradiated (9.5 Gy) WT or CL mice. ...
<p>(A) Absolute number of human cells in lymph nodes, bone marrow and spleens of group 1 and group 7...
<p>(A) Representative flowcytometric results of EV- or MLL-AF10-transduced human hematopoietic cells...
<p>Analyses were performed on day 14 after second transplantation. (A) Continuous HSCT: To evaluate ...
<p>Peripheral blood chimerism analysis (% of hCD45<sup>+</sup> cells) was performed by flow cytometr...
<p>Blood chimerism was assessed by flow cytometry 8 weeks following transplantation of GFP<sup>+/-</...
<p>(A) Hematologic characteristics of myeloid leukemias including peripheral leukocyte counts and sp...
<p>C57Bl/6 mice were reconstituted with BM cells transduced with control MigR1 or <i>Nfix</i> vector...
<p>NSGS mice transplanted with control cells (MIG mice) and <i>BCR-ABL1</i> expressing cells (BA mic...
Representative flow plots from week 16 engrafted mice showing lineage distribution in A) spleen and ...
<p>C57Bl/6 mice were reconstituted with BM cells transduced with control MigR1 or <i>Nfix</i> vector...
<p>(<b>A</b>) Proportion of <i>Crebbp</i><sup><i>+/-</i></sup> cell-derived reconstitution (CD45.2<s...
<p>(A) and (B) Two months following BM transplantation, the four groups of mice were sacrificed and ...
<p>(A) Frequencies of GFP<sup>+</sup>/Venus<sup>+</sup> cells or human CD45<sup>+</sup> cells in the...
A) Averages and B) representative FACS analysis of UCB-engrafted BM demonstrating higher CD33+ and l...
<p>1×10<sup>6</sup> CD45.1 WBMCs were transplanted into lethally irradiated (9.5 Gy) WT or CL mice. ...
<p>(A) Absolute number of human cells in lymph nodes, bone marrow and spleens of group 1 and group 7...
<p>(A) Representative flowcytometric results of EV- or MLL-AF10-transduced human hematopoietic cells...
<p>Analyses were performed on day 14 after second transplantation. (A) Continuous HSCT: To evaluate ...
<p>Peripheral blood chimerism analysis (% of hCD45<sup>+</sup> cells) was performed by flow cytometr...
<p>Blood chimerism was assessed by flow cytometry 8 weeks following transplantation of GFP<sup>+/-</...